Anyone with autoimmune disease, cancer history, or on multiple medications should consult a doctor before experimenting because BPC157 is, in all practical terms, an unapproved drug with unknown interactions
Biological plausibility arguments cut both ways: KLOW's mechanisms don't suggest catastrophic toxicity, but they do suggest pathways for subtle, delayed effects that would only surface in long-duration cohorts
Only studies published in English between 20142025 were considered
Weight loss is not just about willpower
Insulin syringes
Ally Hirschlag Editor and Tester Ally Hirschlag is an award-winning journalist with over 10 years of experience editing and writing health, fitness, beauty, lifestyle, and science content